Evidence map›Paper›PMID 38294335›Full record

ReviewJournal of comparative effectiveness research2024

Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA.

Sikander Ailawadhi, Arliene Ravelo, Carmen D Ng, Bonny Shah, Neil Lamarre, Rongrong Wang, Katherine Eakle, Juliana Ml Biondo

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of comparative effectiveness research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sikander AilawadhiMayo Clinic, Jacksonville, FL 32224, USA.ORCID 0000-0002-8377-8111
Arliene RaveloGenentech, South San Francisco, CA 94080, USA.
Carmen D NgGenentech, South San Francisco, CA 94080, USA.
Bonny ShahGenesis Research, Hoboken, NJ 07030, USA.
Neil LamarreGenesis Research, Hoboken, NJ 07030, USA.
Rongrong WangGenentech, South San Francisco, CA 94080, USA.
Katherine EakleGenentech, South San Francisco, CA 94080, USA.
Juliana Ml BiondoGenentech, South San Francisco, CA 94080, USA.
WinnMed · US

Funding

NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032I
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellNeoplasms, Second PrimaryAgedHumansMedicareRetrospective StudiesSurvivorsUnited Stateschronic lymphocytic leukemiamanagementreal-worldsecond primary malignanciestreatment

Identifiers

PMID38294335
PMCPMC10842294
OpenAlexW4391385875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.